When the blood glucose and the HbA1c don't match: Turning uncertainty into opportunity

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2421-2423

  Cohen, Robert M ^a,b   Lindsell, Christopher J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCATION; GLYCEMIC CONTROL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MEDICAL INFORMATION; NOTE; RETINOPATHY; UNCERTAINTY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84869778654     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1479     Document Type: Note

References (36)

1. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478
2. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
3. Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012;97:1067-1072
4. Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab 2010;95:5203-5206
5. Herman WH, Ma Y, Uwaifo G, et al.; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30: 2453-2457 (Pubitemid 47547771)
6. Viberti G, Lachin J, Holman R, et al.; for the ADOPT Study Group. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe. Diabet Med 2006;23:1289-1294 (Pubitemid 44787790)
7. Herman WH, Dungan KM, Wolffenbuttel BH, et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009;94:1689-1694
8. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-777
9. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011;154: 303-309
10. Herman WH, Cohen RM. Hemoglobin A1c: teaching a new dog old tricks. Ann Intern Med 2010;152:815-817
11. Tsugawa Y, Mukamal KJ, Davis RB, Taylor WC, Wee CC. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med 2012;157:153-159
12. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001;50:2858-2863 (Pubitemid 33733139)
13. Cohen RM, Snieder H, Lindsell CJ, et al. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care 2006;29:1739-1743 (Pubitemid 44156623)
14. Leslie RD, Cohen RM. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. J Diabetes Sci Tech 2009;3:635-643
15. Simonis-Bik AM, Eekhoff EM, Diamant M, et al. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet 2008;11:597-602
16. Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-4291
17. Lindsell CJ, Franco RS, Smith EP, Joiner CH, Cohen RM. A method for the continuous calculation of the age of labeled red blood cells. Am J Hematol 2008;83:454-457 (Pubitemid 351742792)
18. Rodríguez-Segade S, Rodríguez J, García Lopez JM, Casanueva FF, Camiňa F. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care 2012;35:2447-2450
19. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002; 16:313-320
20. Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 1999;36:451-459
21. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in nondiabetic subjects not related to glycaemia. Diabetologia 1990;33:208-215 (Pubitemid 20136237)
22. Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the variability of glycated haemoglobin in nondiabetic subjects not related to glycaemia. Clin Chim Acta 1997;260:49-64 (Pubitemid 27136412)
23. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-167 (Pubitemid 36929010)
24. Cohen RM, LeCaire TJ, Lindsell CJ, Smith EP, D'Alessio DJ. Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction. Diabetes Care 2008;31: 151-153
25. Rodríguez-Segade S, Rodríguez J, Cabezas- Agricola JM, Casanueva FF, Camiña F. Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c). Clin Chem 2011;57:264-271
26. Nayak AU, Holland MR, Macdonald DR, Nevill A, Singh BM. Evidence for consistency of the glycation gap in diabetes. Diabetes Care 2011;34:1712-1716
27. Sacks DB, Nathan DM, Lachin JM. Gaps in the glycation gap hypothesis. Clin Chem 2011;57:150-152
28. Lachin JM, Genuth S, Nathan DM, Rutledge BN. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial. Diabetes 2007;56:1913-1921 (Pubitemid 47025457)
29. Khera PK, Joiner CH, Carruthers A, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-2452
30. Paré G, Chasman DI, Parker AN, et al. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. PLoS Genet 2008;4:e1000312
31. Paterson AD, Waggott D, Boright AP, et al.; MAGIC (Meta-Analyses of Glucose and Insulin-related traits Consortium); Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes 2010; 59:539-549
32. Florez JC. A genome-wide association study of treated A1C: a genetic needle in an environmental haystack? Diabetes 2010; 59:332-334
33. Cohen RM. A1C: does one size fit all? Diabetes Care 2007;30:2756-2758 (Pubitemid 47547834)
34. Sacks DB. Measurement of hemoglobin A1c: a new twist on the path to harmony. Diabetes Care 2012;35:2674-2680
35. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
36. Hirsch IB, Brownlee M. Beyond hemoglobin A1c - need for additional markers of risk for diabetic microvascular complications. JAMA 2010;303:2291-2292